Andrew Alexis

No bio available.

Financial relationships

  • Attribution:
    Spouse or Partner
    Type of financial relationship:
    Advisor
    Ineligible company:
    Dermavant Sciences/Organon, Eli Lilly and Company, Genentech, Regeneron-Sanofi, and has served as a speaker for Incyte, Eli Lilly and Company, and Regeneron-Sanofi
    Topic:
    Atopic Dermatitis
    Date added:
    06/11/2026
    Date updated:
    06/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    AbbVie, Almirall, Amgen, Arcutis, Castle Biosciences,Caudalie,Dermavant, Galderma,Genentech, Incyte, Leo Pharma, Takeda
    Topic:
    Atopic Dermatitis
    Date added:
    06/11/2026
    Date updated:
    06/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    AbbVie, Allergan, Almirall, Alphyn, Alumis, Amgen, Apogee BioPharm, Arcutis, BauschHealth, Beiersdorf, Inc., Boehringer Ingelheim, Botanix Pharmaceuticals, Bristol-MyersSquibb, Canfield Scientific, Castle Biosciences, Dermavant, Dermsquared, Eli Lilly, Ga
    Topic:
    Atopic Dermatitis
    Date added:
    06/11/2026
    Date updated:
    06/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    AbbVie, Aerolase, Johnson & Johnson, L'Oréal , Sanofi/Regeneron, Scientis
    Topic:
    Atopic Dermatitis
    Date added:
    06/11/2026
    Date updated:
    06/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Royalties or patent beneficiary
    Ineligible company:
    Elsevier, Springer, UpToDate, Inc. (Wolters Kluwer Health), Wiley-Blackwell
    Date added:
    06/11/2026
    Date updated:
    06/11/2026
Return to FAAIS 2026 Annual Meeting